Patent · US Expired

Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds

US5618814A · kind A · utility

22Cited by
2References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 2, 1994
Grant dateApr 8, 1997
Priority date
Expiry dateAug 2, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to trisubstituted pyrimido [5,4-d]-pyrimidines of general formula ##STR1## (wherein R.sub.a, R.sub.b and R.sub.c are defined as in claim 1) and the salts thereof, more particularly for pharmaceutical use the physiologically acceptable salts thereof, which have, inter alia, valuable pharmacological properties, particularly in chemotherapy a sensitizing effect on resistant tumors, the use thereof and processes for preparing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.